Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection
β Scribed by Jee-Fu Huang; Chung-Feng Huang; Ming-Lung Yu; Chia-Yen Dai; Ching-I Huang; Ming-Lun Yeh; Meng-Hsuan Hsieh; Jeng-Fu Yang; Ming-Yen Hsieh; Zu-Yau Lin; Shinn-Chern Chen; Wan-Long Chuang
- Book ID
- 108953852
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 193 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background BehΓ§et's syndrome is a systemic, relapsing immuno-inflammatory disease with a generalized vasculitis of the microvasculature endothelial dysfunction. Leptin, a recently discovered neuroendocrine hormone, is a metabolic peptide that appears to be involved. Serum proinflammatory cytokines u
## Abstract Several factors, including metabolic profile, are predictive of response to standard antiviral therapy in patients with chronic hepatitis C. In a retrospective study, it was investigated whether uric acid, involved in metabolic syndrome, could be included. A total of 153 patients (56.2%